Results 101 to 110 of about 667 (143)
Some of the next articles are maybe not open access.

Succimer, an oral lead chelator.

Clinical pharmacy, 1992
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of succimer when used for the treatment of lead poisoning are reviewed. Succimer is an orally active, heavy-metal chelating agent that forms stable, water-soluble complexes with lead; it also chelates other toxic heavy metals, such as arsenic and ...
K V, Mann, J D, Travers
openaire   +1 more source

A report of pediatric SUCCIMER overdose.

Veterinary and human toxicology, 1998
A 3-y-old child ingested SUCCIMER capsules to receive a dose of 185 mg dimercaptosuccinic acid/kg body weight. No adverse effects occurred.
T, Sigg   +4 more
openaire   +1 more source

Succimer

Reactions Weekly, 2012
openaire   +1 more source

Succimer

Reactions Weekly, 1991
openaire   +1 more source

Succimer: the first approved oral lead chelator.

American family physician, 1994
The Centers for Disease Control and Prevention has redefined the threshold of concern for low-level lead toxicity, reducing it from a blood lead level of 25 micrograms per dL (1.21 mumol per L) to a blood lead level of 10 micrograms per dL (0.48 mumol per L), and has recommended universal screening of young children.
openaire   +1 more source

Formulation of technetium 99-m succimer injection

Three formulations of Ready-To-Use kit for preparation of Technetium Tc 99m Succimer Injections have been prepared in lyophilized form and packed in nitrogen atmosphere. The formulation 1 contained succimer and stannous chloride by the mole ratio of 3:1, pH 2.5.
openaire   +1 more source

Succimer

Reactions Weekly, 2015
openaire   +1 more source

Antibacterial/succimer

Reactions Weekly, 2018
openaire   +1 more source

Home - About - Disclaimer - Privacy